Drug Shortage Report for TARO-ACITRETIN
Report ID | 215061 |
Drug Identification Number | 02466074 |
Brand name | TARO-ACITRETIN |
Common or Proper name | ACITRETIN |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | ACITRETIN |
Strength(s) | 10MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | D05BB |
ATC description | ANTIPSORIATICS FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-09-15 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-06-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-06-14 | French | Compare |
v5 | 2024-06-14 | English | Compare |
v4 | 2024-05-07 | French | Compare |
v3 | 2024-05-07 | English | Compare |
v2 | 2024-01-05 | French | Compare |
v1 | 2024-01-05 | English | Compare |
Showing 1 to 6 of 6